Inactive Instrument

All News Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : Galapagos NV, Q1 2024 Earnings Call, May 03, 2024	May. 03
Galapagos : Galapagos reports first quarter 2024 financial results	May. 03	PU
Galapagos reports first quarter 2024 financial results	May. 02	GL
Galapagos NV Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI
Galapagos : Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	May. 01	PU
Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024	Apr. 30	GL
Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024	Apr. 08	CI
Galapagos : Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	Apr. 05	PU
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	Apr. 04	GL
Galapagos : Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	Mar. 29	PU
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	Mar. 28	GL
Galapagos Continues to be 'Value Trap' With Unclear Growth Path, BofA Says	Mar. 28	MT
BofA Securities Downgrades Galapagos to Underperform From Neutral, Says 'Stock Remains a Value Trap'; Adjusts Price Target to $31 From $41	Mar. 28	MT
Galapagos NV Announces Board Changes	Mar. 27	CI
Galapagos : Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur	Mar. 27	PU
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board	Mar. 26	GL
Galapagos to Seek Acquisitions	Feb. 23	CI
Transcript : Galapagos NV, 2023 Earnings Call, Feb 23, 2024	Feb. 23
Galapagos announces full year 2023 results and outlook for 2024	Feb. 22	GL
Frontier Medicines Corporation announced that it has received $80.000001 million in funding from Deerfield Management Company, L.P. Series C, DROIA nv, Galapagos NV, DCVC, MPM Asset Management, L.L.C., RA Capital Management, L.P. and other investors	Feb. 21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

All News

Filters